Precision Biosciences (DTIL) Total Debt (2021 - 2026)

Precision Biosciences (DTIL) has 5 years of Total Debt data on file, last reported at $22.4 million in Q1 2026.

• Total Debt for Q1 2026 came in at $22.4 million, changed 0.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.4 million (changed 0.37% YoY), and the FY2025 annual result was $22.4 million, changed 0.37% from the prior year.
• Total Debt held at $22.4 million in Q1 2026 per DTIL's latest filing, from $22.4 million in the prior quarter.
• Over five years, Total Debt peaked at $22.5 million in Q2 2024 and troughed at $22.3 million in Q3 2024.
• A 4-year average of $22.4 million and a median of $22.4 million in 2023 frame the typical range for Total Debt.
• The sharpest annual moves came in 2024 and 2025: Total Debt increased 0.79% in 2024, then fell 0.62% in 2025.
• A 4-year view of Total Debt shows it stood at $22.4 million in 2023, then retreated by 0.41% to $22.3 million in 2024, then grew by 0.37% to $22.4 million in 2025, then grew by 0.07% to $22.4 million in 2026.
• Business Quant data shows DTIL's Total Debt at $22.4 million in Q1 2026, $22.4 million in Q4 2025, and $22.4 million in Q3 2025.